Use of a T-lymphocyte clonal assay for determining HPRT mutant frequencies in individual rats.

[1]  H. Vrieling,et al.  The gene encoding hypoxanthine-guanine phosphoribosyltransferase as target for mutational analysis: PCR cloning and sequencing of the cDNA from the rat. , 1992, Mutation research.

[2]  A. Zwinderman,et al.  Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations. , 1991, Mutation research.

[3]  A. Tates,et al.  Biological and chemical monitoring of occupational exposure to ethylene oxide. , 1991, Mutation research.

[4]  A. Zwinderman,et al.  Radionuclide angiography with technetium-99m in vivo labeled erythrocytes does not lead to induction of mutations in the HPRT gene of human T-lymphocytes. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  T. Skopek,et al.  DNA sequence analysis of in vivo hprt mutation in human T lymphocytes. , 1990, Mutagenesis.

[6]  A. Tates,et al.  Mutations affecting RNA splicing in man are detected more frequently in somatic than in germ cells. , 1990, Mutation research.

[7]  R. Albertini,et al.  In vivo hprt mutant frequencies in T-cells of normal human newborns. , 1990, Mutation research.

[8]  J. Ferraris,et al.  Mutant frequency of radiotherapy technicians appears to be associated with recent dose of ionizing radiation. , 1989, Health physics.

[9]  R. Pabst,et al.  Proliferation of lymphocyte subsets in the adult rat: a comparison of different lymphoid organs , 1989, European journal of immunology.

[10]  P. Druet,et al.  Autoreactive T cells in mercury‐induced autoimmunity. Demonstration by limiting dilution analysis , 1988, European journal of immunology.

[11]  R. Albertini,et al.  Mutagenicity monitoring in humans by autoradiographic assay for mutant T lymphocytes. , 1988, Mutation research.

[12]  M. Green,et al.  A further assessment of factors influencing measurements of thioguanine-resistant mutant frequency in circulating T-lymphocytes. , 1988, Mutation research.

[13]  I. M. Jones,et al.  Cloned mouse lymphocytes permit analysis of somatic mutations that occur in vivo , 1987, Somatic cell and molecular genetics.

[14]  W. M. Linehan,et al.  A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. , 1987, The New England journal of medicine.

[15]  R. Albertini,et al.  Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. , 1987, Mutagenesis.

[16]  A. Morley,et al.  Mutation rate of normal and malignant human lymphocytes. , 1987, Cancer research.

[17]  M. Green,et al.  Detection of somatic mutations in man: evaluation of the microtitre cloning assay for T-lymphocytes. , 1986, Mutagenesis.

[18]  T. Makinodan,et al.  Frequency of 6-thioguanine-resistant T cells is inversely related to the declining T-cell activities in aging mice. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  I. M. Jones,et al.  A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes. , 1985, Mutation research.

[20]  R. Albertini.  Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood. , 1985, Mutation research.

[21]  Kevin J. Trainor,et al.  Mutation frequency in human lymphocytes increases with age , 1984, Mechanisms of Ageing and Development.

[22]  E. Gocke,et al.  Autoradiographic detection of 6-thioguanine-resistant lymphocytes of mice. A novel system in somatic mutagenesis testing. , 1983, Mutation research.

[23]  G. Zbinden,et al.  THE GRANULOMA POUCH ASSAY , 1983 .

[24]  Kevin J. Trainor,et al.  Measurement of in vivo mutations in human lymphocytes , 1983, Nature.

[25]  H. Liber,et al.  Mutation assay at the thymidine kinase locus in diploid human lymphoblasts. , 1982, Mutation research.

[26]  B. Bridges,et al.  The three-tier approach to mutagenicity screening and the concept of radiation-equivalent dose. , 1974, Mutation research.

[27]  L. Ehrenberg,et al.  Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide. , 1974, Mutation research.

[28]  Tilney Nl.  Patterns of lymphatic drainage in the adult laboratory rat. , 1971 .

[29]  R. Albertini,et al.  Enumeration of 6‐thioguanine‐resistant T‐lymphocytes in the peripheral blood of nonhuman primates (cynomolgus monkeys) , 1991, Environmental and molecular mutagenesis.

[30]  L. Ehrenberg.  Detection and measurement of protein adducts: aspects of risk assessment. , 1991, Progress in clinical and biological research.

[31]  R. Mittelstaedt,et al.  Induction of 6‐thioguanine‐resistant lymphocytes in fischer 344 rats following in vivo exposure to n‐ethyl‐n‐nitrosourea and cyclophosphamide , 1991, Environmental and molecular mutagenesis.

[32]  D. Beare,et al.  HPRT somatic mutation data. , 1990, Progress in clinical and biological research.

[33]  T. Skopek,et al.  hprt mutations in vivo in human T-lymphocytes: frequencies, spectra and clonality. , 1990, Progress in clinical and biological research.

[34]  A. Awa,et al.  Measurement of in vivo HGPRT-deficient mutant cell frequency using a modified method for cloning human peripheral blood T-lymphocytes. , 1988, Mutation research.

[35]  R. Albertini,et al.  Use of T-cell receptor gene probes to quantify the in vivo hprt mutations in human T-lymphocytes. , 1986, Mutation research.

[36]  E. Furth,et al.  Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates. , 1981, Analytical biochemistry.